Search
for
Sort by
Research 361–390 of 1000+
- Gonadotrophin-releasing hormone agonist therapy for hirsutism is as effective as high dose cyproterone acetate but results in a longer remission
- Analysis of sequential hair segments reflects changes in the metabolome across the trimesters of pregnancy
- Prevalence of androgenic alopecia in patients with polycystic ovary syndrome and characterization of associated clinical and biochemical features
- A Randomized Trial of Oral DHEA Treatment for Sexual Function, Well-Being, and Menopausal Symptoms in Postmenopausal Women with Low Libido
- Adult female acne and associated risk factors: Results of a multicenter case-control study in Italy
- Putative role for insulin resistance in depression risk in polycystic ovary syndrome
- Association of premature hair graying with family history, smoking, and obesity: A cross-sectional study
- The safety of 52 weeks of oral DHEA therapy for postmenopausal women
- Altered autonomic neural control of the cardiovascular system in patients with polycystic ovary syndrome
- Effects of melatonin administration on mental health parameters, metabolic and genetic profiles in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial
- Prevalence of hepatic steatosis in women with polycystic ovary syndrome
- Lipid levels in patients with lichen planus: a case-control study
- Serum Levels of Retinol-Binding Protein 4 and Adiponectin in Women with Polycystic Ovary Syndrome: Associations with Visceral Fat But No Evidence for Fat Mass-Independent Effects on Pathogenesis in This Condition
- Ghrelin levels are suppressed and show a blunted response to oral glucose in women with polycystic ovary syndrome.
- Androgen receptor gene CAG repeat polymorphism in women with polycystic ovary syndrome
- Insulin resistance and obesity among infertile women with different polycystic ovary syndrome phenotypes
- 17-Hydroxyprogesterone Responses to Gonadotropin-Releasing Hormone Disclose Distinct Phenotypes of Functional Ovarian Hyperandrogenism and Polycystic Ovary Syndrome
- Evidence for Increased 5α-Reductase Activity During Early Childhood in Daughters of Women With Polycystic Ovary Syndrome
- Associations between transition‐specific stress experience, nocturnal decline in ambulatory blood pressure, and C‐reactive protein levels among transgender men
- Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome.
- Polycystic ovary syndrome in Salvador, Brazil: a prevalence study in primary healthcare
- What may be the markers of the male equivalent of polycystic ovary syndrome?
- Psychocutaneous disease
- Effect of a nutritional supplement on hair loss in women
- The effect of weight loss and treatment with metformin on serum vaspin levels in women with polycystic ovary syndrome
- Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam’s criteria and women whose only clinical signs are oligo/anovulation or hirsutism
- Shorter CAG repeats in the androgen receptor gene may enhance hyperandrogenicity in polycystic ovary syndrome
- Pharmacologic Therapy of Polycystic Ovary Syndrome
- Prevalence of Polycystic Ovary Syndrome in Girls Aged 14–18 Years in Isfahan, Iran
- Vitamin D receptor polymorphisms and the polycystic ovary syndrome: A systematic review